CHD Patients with Diabetes (n = 115) | CHD Patients without Diabetes (n = 97) | |
---|---|---|
Age(yr) | 67.1 ± 9.7 | 63.7 ± 8.3 |
Female/Male | 45/70 | 53/44 |
SBP(mmHg) | 135.2 ± 20.6 | 130.8 ± 17.7 |
DBP(mmHg) | 77.6 ± 8.4 | 75.7 ± 7.5 |
BMI(kg/m 2 ) | 25.0 ± 2.6 | 24.3 ± 2.1 |
Waist (cm) | 92.4 ± 8.6 | 88.1 ± 7.8† |
Hip (cm) | 94.2 ± 6.4 | 93.1 ± 5.7 |
WHR | 0.98 ± 0.1 | 0.94 ± 0.1† |
Gensini Score | 53.7 ± 9.2 | 22.9 ± 6.3† |
FPG(mmol/L) | 9.0 ± 1.2 | 5.2 ± 0.6‡ |
TG(mmol/L) | 2.2 ± 0.5 | 1.8 ± 0.6* |
TC(mmol/L) | 4.4 ± 1.1 | 3.9 ± 1.0* |
LDL-C(mmol/L) | 3.4 ± 1.0 | 2.7 ± 0.7† |
HDL-C(mmol/L) | 1.0 ± 0.2 | 1.3 ± 0.2† |
ApoA-I(g/L) | 1.1 ± 0.2 | 1.3 ± 0.3* |
ApoB-100(g/L) | 0.8 ± 0.2 | 0.6 ± 0.2* |
ApoB-100/A-I | 0.7 ± 0.2 | 0.5 ± 0.1* |
Preβ 1 -HDL(mg/L) | 92.0 ± 9.5 | 83.0 ± 7.0 |
HDL 3c (mg/L) | 83.9 ± 7.4 | 78.5 ± 6.9 |
HDL 3b (mg/L) | 170.2 ± 20.9 | 142.5 ± 18.2* |
HDL 3a (mg/L) | 310.5 ± 44.7 | 272.5 ± 38.1* |
HDL 2a (mg/L) | 190.5 ± 25.8 | 285.9 ± 42.2‡ |
HDL 2b+Preβ2-HDL (mg/L) | 311.9 ± 52.2 | 389.3 ± 69.5‡ |